- Home
- DT vs BAX Comparison
DT vs BAX Comparison
Compare DT & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DT
- BAX
- Stock Information
- Founded
- DT 2005
- BAX 1931
- Country
- DT United States
- BAX United States
- Employees
- DT N/A
- BAX N/A
- Industry
- DT Computer Software: Prepackaged Software
- BAX Medical/Dental Instruments
- Sector
- DT Technology
- BAX Health Care
- Exchange
- DT Nasdaq
- BAX Nasdaq
- Market Cap
- DT 16.3B
- BAX 14.1B
- IPO Year
- DT 2019
- BAX N/A
- Fundamental
- Price
- DT $54.18
- BAX $29.23
- Analyst Decision
- DT Buy
- BAX Buy
- Analyst Count
- DT 24
- BAX 8
- Target Price
- DT $61.43
- BAX $36.38
- AVG Volume (30 Days)
- DT 2.3M
- BAX 4.8M
- Earning Date
- DT 08-06-2025
- BAX 07-31-2025
- Dividend Yield
- DT N/A
- BAX 2.32%
- EPS Growth
- DT 205.77
- BAX N/A
- EPS
- DT 1.59
- BAX N/A
- Revenue
- DT $1,698,683,000.00
- BAX $10,771,000,000.00
- Revenue This Year
- DT $18.80
- BAX $8.05
- Revenue Next Year
- DT $14.57
- BAX $4.19
- P/E Ratio
- DT $34.05
- BAX N/A
- Revenue Growth
- DT 18.75
- BAX 15.36
- 52 Week Low
- DT $39.30
- BAX $26.25
- 52 Week High
- DT $63.00
- BAX $40.49
- Technical
- Relative Strength Index (RSI)
- DT 52.95
- BAX 49.76
- Support Level
- DT $52.07
- BAX $29.57
- Resistance Level
- DT $53.81
- BAX $31.15
- Average True Range (ATR)
- DT 1.39
- BAX 0.85
- MACD
- DT 0.00
- BAX 0.03
- Stochastic Oscillator
- DT 47.43
- BAX 49.07
About DT Dynatrace Inc.
Dynatrace is a cloud-native company that focuses on analyzing machine data. Its product portfolio, delivered as software as a service, allows a client to monitor and analyze its entire IT infrastructure. Dynatrace's platform can ingest and analyze large amounts of machine-generated data in real time, allowing clients to use it for a variety of applications throughout their businesses.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.